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Abstract
Background: The shoulder is the most frequently dislocated joint in the body. Multiple causes and pathologies account for the
various types of shoulder instability. Multi-directional instability (MDI) and multi-directional laxity with antero-inferior instability
(MDL-AII) are similar in pathology, less common and more difficult to treat. These instabilities are caused by ligamentous
capsular redundancy. When non-operative management fails for these patients, quality of life is significantly impaired and surgical
treatment is required to tighten the ligaments and joint capsule. The current reference (gold) standard treatment for MDI/MDL-
AII is an open inferior capsular shift (ICS) surgical procedure. An alternative treatment involves arthroscopic thermal shrinkage
of redundant capsular tissue to tighten the joint. However, there is a lack of scientific evidence to support the use of this
technique called, electrothermal arthroscopic capsulorrhaphy (ETAC). This trial will compare the effectiveness of ETAC to open
ICS in patients with MDI and MDL-AII, using patient-based quality of life outcome assessments.
Methods: This study is a multi-centre randomized clinical trial with a calculated sample size of 58 patients (p = 0.05, 80%
power). Eligible patients are clinically diagnosed with MDI or MDL-AII and have failed standardized non-operative management.
A diagnostic shoulder arthroscopy is performed to confirm eligibility, followed by intra-operative randomization to the ETAC
or ICS surgical procedure. The primary outcome is the disease-specific quality of life questionnaire (Western Ontario Shoulder
Instability Index), measured at baseline, 3, 6, 12 and 24 months. Secondary outcomes include shoulder-specific measures
(American Shoulder and Elbow Surgeons Score and Constant Score). Other outcomes include recurrent instability,
complications and operative time.
The outcome measurements will be compared on an intention-to-treat basis, using two-sample independent t-tests to assess
statistical significance. A Generalized Estimated Equations (GEE) analysis will determine whether there is an effect over time.
Discussion: This ongoing trial has encountered unexpected operational and practical issues, including slow patient enrollment
due to high intra-operative exclusion rates. However, the authors have a greater understanding of multi-directional laxity in the
shoulder and anticipate the results of this trial will provide the medical community with the best scientific clinical evidence on
the efficacy of ETAC compared to open ICS.
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Background
The shoulder is the most frequently dislocated joint in the
body with an estimated annual incidence of 1–2% [1,2].
Shoulder instability affects people in all decades of life,
most commonly in the late teens to mid thirties, when
people are most active, both recreationally and vocation-
ally. The disability and time loss from work, as well as the
effect on quality of life represent a significant clinical
problem for the population and the healthcare system.
'Shoulder instability' is a generic and somewhat vague
term encompassing a spectrum of disorders, from a pain-
ful shoulder with occult subluxation to frank dislocation.
It can be further classified according to the direction of the
instability (anterior, posterior or multi-directional), the
etiology (traumatic vs. atraumatic), the duration of the
problem (acute vs. chronic or recurrent) and whether it
occurs involuntarily or under the patient's own volition
[3].
The pathology of shoulder instability has been well delin-
eated in the literature. Bankart originally described the
'essential lesion' of recurrent post-traumatic anterior
shoulder instability as capsulolabral avulsion off the ante-
rior-inferior glenoid rim [4,5]. Others have since eluci-
dated the importance of ligaments intrinsic to the
shoulder capsule in maintaining stability of the joint. In
particular, during abduction and external rotation of the
upper arm, the anterior band of the inferior glenohumeral
ligament (IGHL) is placed under tension and restrains
anterior translation of the humeral head [6,7]. The
Bankart lesion ('essential lesion') represents a detachment
of the IGHL's insertion or anchor, limiting its ability to
develop tension and thus allowing for abnormal transla-
tion [8]. From a biomechanical standpoint an analogous
situation occurs if the ligament, while retaining its
anchors, becomes stretched, attenuated or redundant as a
result of repetitive minor trauma or inherent laxity [9,10].
Indeed, this is the main pathological lesion in patients
with multi-directional instability (MDI) and multi-direc-
tional laxity with antero-inferior instability (MDL-AII).
Both of these groups of patients have ligamentous or cap-
sular redundancy as the primary cause of their instability
and present with similar clinical findings.
The initial approach for treatment of MDI and MDL-AII
involves non-surgical rehabilitation, including modifica-
tion of activities, strengthening of the shoulder muscula-
ture and proprioceptive training [11,12]. Should
rehabilitation fail, open and arthroscopic surgical inter-
ventions can be considered. The open Inferior Capsular
Shift (ICS) procedure is the current reference standard
treatment for ligamentous or capsular redundancy
[13,14]. Open ICS involves incising, overlapping and
suturing the capsule, resulting in less capsular redun-
dancy.
In recent years, attention has been focused on arthro-
scopic surgical treatment for all types of shoulder instabil-
ity in an attempt to decrease surgical morbidity and
minimize loss in range of motion [15-19]. The results of
arthroscopic procedures have been previously reported to
be less successful compared to those of equivalent open
surgical procedures in patients with the same type of insta-
bility [15-18,20] because of the inability to address capsu-
lar ligamentous redundancy [21-24]. Although the
arthroscopic suture plication approach minimizes the
damage to the surrounding musculature, it is less effective
for addressing capsular redundancy [25,26].
One existing method to address capsular redundancy is
laser capsulorrhaphy, or laser assisted capsular shrinkage
(LACS), which can be performed arthroscopically, but is
costly and delivers high bursts of energy that can be diffi-
cult to control [27,28]. In addition, some failures due to
"rebound" ligament stretching, technical difficulties, and
laser replacement and maintenance costs remain signifi-
cant concerns. An alternative to laser technology is radio-
frequency energy, which has been used for various appli-
cations in medicine [29-32]. Electrothermal Arthroscopic
Capsulorrhaphy (ETAC) is a more recent procedure
whereby a small radio-frequency probe, or "heat probe"
[29], is inserted through an arthroscopic portal to deliver
heat to the capsular ligamentous tissue. This method
achieves temperatures necessary to denature collagen,
shrinking redundant ligamentous tissue in the shoulder in
a controlled manner, [29-32] thus reducing excess capsu-
lar volume. The ETAC tec hnology allows for more con-
trolled energy delivery, and the ability to monitor the
temperature generated at the probe-tissue interface. Not
only is ETAC less costly and technically easier to perform
than laser technology, it is also less invasive than open
ICS, since it preserves muscle attachments and is less likely
to compromise the proprioceptive control of the shoulder
[33]. However, it is unclear whether these purported ben-
efits of ETAC can improve shoulder instability and patient
quality of life in the population of patients with MDI and
MDL-AII.
Technology, rather than scientific clinical evidence, is
often the driving force in orthopaedic surgery today.
Within the context of shoulder instability, this trend has
been evident with the advent of arthroscopic techniques,
and specifically with the introduction of ETAC. While this
may be a disturbing statement to most surgeons, there are
only five published randomized clinical trials related to
shoulder stabilization surgery [34-38], none of which
have addressed this new technology or the patient popu-
lation with shoulder instability due to capsular redun-Trials 2006, 7:4 http://www.trialsjournal.com/content/7/1/4
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dancy. Recent publications on the thermal treatment of
shoulder instability are limited to retrospective case series
[39-43], with one prospective consecutive series of
patients comparing laser assisted capsular shrinkage
(LACS) to radio-frequency capsular shrinkage (ETAC)
[44]. These publications do not lend themselves to a
meta-analytic approach because of inconsistent defini-
tions of patient populations, combined surgical tech-
niques, variation and lack of validated outcomes, and no
comparative groups. There has been little corroborative
basic science or clinical evidence to support ETAC proce-
dures. This dearth of scientific evidence is in grave contrast
to the numbers of procedures performed. A variety of
authors have repeatedly supported this position [45-51],
emphasizing the need for an appropriate trial that is sub-
sequently evaluated in the context of peer-reviewed
research. Thus, this multi-centre study is designed to com-
pare the theoretical advantages and effectiveness of the
ETAC procedure to the open ICS procedure in the context
of a randomized clinical trial.
Methods
Design
This Canadian study is designed as a national multi-centre
randomized clinical trial with all surgical collaborators
being fellowship-trained shoulder surgeons. The protocol
and informed consent process have been approved by the
University of Calgary Conjoint Health Research Ethics
Board (ID: 10650). In addition, approval has been
granted by the institutional ethics board of each partici-
pating centre in the trial.
The primary objective is to determine if there is a differ-
ence in disease-specific quality of life outcome over 2
years in MDI and MDL-AII patients undergoing open ICS
or ETAC surgery, as measured by the Western Ontario
Shoulder Instability (WOSI) Index [52]. Secondary objec-
tives include determination of: a) the recurrence rate of
instability (post-operative symptomatic subluxation or
dislocation); b) the difference in overall shoulder func-
tional status, as measured by standardized shoulder joint-
specific outcome assessments (American Shoulder and
Elbow Surgeons (ASES) Score [53], and Constant Score
[54]); and c) the difference in surgical time between the
two treatment groups.
Outcome measures
The primary outcome used to compare the treatment
groups is the Western Ontario Shoulder Instability
(WOSI) Index, a self-administered, disease-specific out-
come designed to measure quality of life in patients with
shoulder instability [52]. The WOSI index has 21 ques-
tions, divided into four categories (physical symptoms,
sport/recreation/work, lifestyle, and emotions), whereby
each question is scored on a 100-mm visual analogue
response scale. The responses are measured and summed
to provide an overall score out of 2100. A lower score
reflects a better quality of life. This index has been demon-
strated to be valid, reliable and responsive in a patient
population comparable to that of the proposed study
[52]. In addition, it is used as the primary outcome in
ongoing and published clinical trials investigating trau-
matic anterior shoulder instability [34,55,56], and laser
assisted capsular shift for MDI patients [40]. It should be
made clear, that the scoring as originally described has
been arithmetically converted for the purposes of this trial
to average the scores on each question resulting in a pos-
sible score of 0–100, with 100 being the best possible
score.
One secondary outcome is the American Shoulder and
Elbow Surgeons (ASES) score, a shoulder-specific assess-
ment tool developed by the American Shoulder and
Elbow Surgeons Society for use in all types of shoulder
problems [57]. It consists of both patient self-assessment
and physician assessment components. The patient self-
evaluation is divided into two sections: pain and activities
of daily living (ADL). Pain is recorded on a visual ana-
logue scale and ADL's are recorded on a numeric scale.
The overall score is an equal weight of the two sections
and produces a score out of 100. A higher score reflects a
better outcome. A score is not calculated in the physician
assessment component. This portion is divided into four
segments to provide information about range of motion,
physical signs, strength and instability.
Another secondary outcome is the Constant Score
adopted by the European Shoulder Society for overall
clinical functional assessment of the shoulder [54]. The
Constant Score records a variety of shoulder measure-
ments, including an objective test of strength using a
spring-loaded measuring device. The Constant Score is
based on a 100-point scoring system calculated from a
self-assessment portion that evaluates pain and ability to
perform tasks of daily living, and a clinical assessment
portion that tests shoulder strength and active range of
motion. A higher score reflects a better outcome.
Additional outcomes include the documentation of recur-
rent instability, complications and operative time. Recur-
rent instability is defined as a self-report of one or both of
the following criteria: a) A minimum of two subluxation
events, where subluxation is defined as the symptomatic
translation of the humeral head relative to the glenoid
articular surface [58]; and/or, b) At least one re-disloca-
tion, where dislocation is defined as an increased motion
of the humeral head relative to the glenoid to the point of
complete separation of articular surfaces [58].Trials 2006, 7:4 http://www.trialsjournal.com/content/7/1/4
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The outcome measures are collected at each clinical fol-
low-up appointment in a standardized fashion and by a
trained independent assessor who is blinded to treatment
status. If patients do not return to the clinic or miss an
appointment, all attempts are made to have the question-
naires completed through mail-out or internet-based for-
mats.
Randomization
Consenting patients, clinically diagnosed with either MDI
or MDL-AII, and who have failed non-operative rehabili-
tative management, are randomized to either an ETAC or
open ICS surgical treatment. Computer-generated (STATA
8.2, StataCorp, USA), stratified block randomization is
used to ensure that imbalances between group assign-
ments do not occur during the course of the trial. Stratifi-
cation is based on two variables: 1) surgeon – to account
for any differences between surgeons, and, 2) diagnosis
(MDI and MDL-AII) – to account for any differences in the
severity of pathology. Thus, the stratification process
results in a separate set of sealed numbered opaque enve-
lopes for each participating surgeon and for each type of
shoulder instability (MDI or MDL-AII).
Randomization occurs in the operating room following a
diagnostic arthroscopy. Once the surgeon confirms that
the patient meets the eligibility criteria, the next consecu-
tive envelope is opened by the study research coordinator
or the assigned circulating nurse, which randomly allo-
cates the patient to either open ICS or ETAC treatment. If
the patient is ineligible, the surgeon performs the most
appropriate procedure as he/she sees fit.
Interventions
Open Inferior Capsular Shift (ICS)
The open ICS procedure used in this study was described
by Schenk and Brems [11], which is a modification of
Neer and Foster's original procedure [13]. A standard del-
topectoral approach is utilized. The tendon of the sub-
scapularis is incised 1 cm medial to the lesser tuberosity.
The interval between the tendon and capsule is devel-
oped, working from lateral to medial, until the capsule is
completely exposed. No muscle is left on the capsule. The
rotator interval is identified and, if a rotator interval lesion
is present, it is closed using number 1 non-absorbable
sutures. This is done with the arm adducted and externally
rotated 30 degrees. The capsule is incised in a T-shaped
fashion with the vertical limb based laterally and the
transverse limb placed so as to lie perpendicular to the gle-
noid and intersect it near its equator. In patients with
MDI, the lateral capsule is released antero-superiorly from
the rotator interval to the equator posteriorly on the
humeral neck. In patients with MDL-AII, the release
extends from the rotator interval to the 7 o'clock position
(right shoulder) or 5 o'clock position (left shoulder) on
the neck of the humerus. This effectively tightens the two
bands of the inferior glenohumeral ligaments, the middle
glenohumeral ligament and the rotator interval. The bone
adjacent to the articular surface on the surgical neck of the
humerus is roughened to create a bleeding bony bed.
With the arm held in 0 degrees flexion, 30 degrees abduc-
tion, 30 degrees external rotation, the inferior leaflet of
the capsule is shifted superiorly and slightly laterally and
sutured using a non-absorbable suture to the rim of the
capsule remaining laterally [59]. The superior leaflet is
shifted inferiorly and sutured in a similar fashion. The
subscapularis is repaired at its anatomic length using
interrupted sutures. The skin is closed in the usual fash-
ion, dressings applied and the shoulder placed in a shoul-
der immobilizer.
Electrothermal Arthroscopic Capsulorrhaphy (ETAC)
The Oratec Vulcan Generator electro-thermal system
(Oratec Interventions Inc., Menlo Park, CA, USA) is the
energy system utilized for the ETAC arm of the trial. The
unit is automatically set to deliver a temperature of 75
degrees Celsius and 40 watts [60]. Following or during
diagnostic arthroscopy, an anterior working portal is
established just above the superior border of the sub-
scapularis tendon such that access to the inferior recess of
the joint is easily attainable. In patients with MDI, the
arthroscope is moved to the anterior portal and the heat
probe is introduced through the posterior portal. The cap-
sule is shrunk using a grid pattern [61] until excess volume
is diminished. The extent of the heat probe application is
identical to the landmarks used for the open ICS. Care is
taken to avoid applying heat to the capsule in the region
from 5–7 o'clock within 1 centimetre of the rim of the gle-
noid – this is done to avoid the axillary nerve at its most
vulnerable point [62]. The current method of heat appli-
cation utilizes a grid pattern, as determined by recent basic
science work [61]. This pattern is less likely to cause disso-
lution of the capsule and subsequent catastrophic capsu-
lar loss, as reported by Weber [63]. The portals are closed
in the usual fashion, dressings applied and the shoulder
placed in a shoulder immobilizer.
In both surgical arms of the study the duration of the sur-
gical procedure and any intra-operative complications are
noted. The patients remain in hospital until pain and nau-
sea control is achieved using standard treatments accord-
ing to each surgeon. This may include both out-patient
and in-patient surgery depending upon the patient and
surgeon preferences.
Post-operative immobilization and rehabilitation are
identical in both groups.Trials 2006, 7:4 http://www.trialsjournal.com/content/7/1/4
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Subjects
Eligible subjects are assessed in the clinic and must meet
the following inclusion criteria:
a) Age 14 years or greater.
b) Diagnosis of MDI [13] or MDL-AII [64]. Diagnosis will
require two or more of the following:
i. symptomatic translation (pain or discomfort) in one or
more directions: anterior, inferior and/or posterior.
ii. ability to elicit unwanted glenohumeral translations
that reliably reproduce symptoms with one of the follow-
ing tests: anterior and posterior apprehension tests, the
anterior and posterior load and shift tests, the fulcrum
test, the relocation test, the Fukuda test and/or the push-
pull or stress test with the patient supine [65].
iii. presence of a positive sulcus sign of 1 centimetre or
greater gap that reproduces the patient's clinical symp-
toms of instability and should be both palpable and visi-
ble.
iv. symptoms of instability: subluxation or dislocation
c) Informed written consent.
d) Failed at least 6 months of non-operative treatment.
e) Confirmed capsular-ligamentous redundancy as deter-
mined by diagnostic arthroscopy examination.
Subjects meeting the following criteria are excluded from
the study:
a) Neurologic disorder (e.g. axillary nerve injury; syringo-
myelia).
b) Cases involving third party compensation.
c) Patients with primary posterior instability.
d) A bony abnormality (Hill Sachs/Bony Bankart) on
standard series of x-rays consisting of a minimum of an
antero-posterior view, lateral in the scapular plane and an
axillary view.
e) Presence of a Bankart lesion on arthroscopic exam of
the joint.
f) Presence of an unstable biceps anchor, (e.g. SLAP lesion
[66]), on arthroscopic exam of the joint.
g) Presence of a full thickness rotator cuff tear, on arthro-
scopic exam of the joint.
Sample Size Calculation
Minimal Clinically Important Difference (MCID)
A utility index model [67-69] was utilized by the authors
of this trial to determine the MCID for the WOSI ques-
tionnaire. First, patients completed the WOSI and were
informed of their score converted to an average out of
100. For the purposes of this pilot study, the 100-point
WOSI index was reversed such that a score of 100 repre-
sented the best possible quality of life score and 0 the
worst. Then, using this system, patients were asked: 'What
is the smallest increase in your score that you would con-
sider to represent a 'significant improvement'? A pilot
study of 15 MDI patients illustrated that an averaged
MCID for improved quality of life was 32.7 points (range
20 points to 50 points) with a median score of 30 points
(data not shown). Based on the lower end of the range
and the median, an MCID of 20 points was chosen. Fur-
thermore, the authors and collaborators of this study met
(London, ON, Canada: June, 2001) and collectively
agreed on a 20 point (20%) change in the overall score as
a clinically important difference, while blinded to the
results of the pilot patient project. Therefore, choosing a
20% difference in group means ensures a sufficient sam-
ple size to test the alternative hypothesis that the ETAC
procedure demonstrates a different outcome from the
standard ICS. In addition, the smaller mean difference of
20% was chosen to calculate a more conservative sample
size; therefore minimizing the chance of making a Type II
error.
Sample size
The sample size calculation is based on the existing base-
line information from the first thirty patients entered into
the trial. The first 30 patients had a mean WOSI score of
1461.68 with a normal distribution of the data and a
standard deviation of 364.52. The estimated minimal
clinically important difference between treatment groups
is 20%.
Sample size parameters:
▪ Comparing 2 independent group means with a MCID
between means = 20%
▪ Mean group 1 = 1461.68; Mean group 2 = 1169.34;
Standard Deviation (SD) = 364.52
▪ Predicted patient drop-out rate (based on drop-out rate
to date) = 12%Trials 2006, 7:4 http://www.trialsjournal.com/content/7/1/4
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Using these sample size parameters, an alpha value p =
0.05, and 80% power, the calculated sample size is 29
patients per group (Table 1).
Blinding
Due to the nature of this surgical trial, the surgeon and the
patient are not blinded to the intervention. However, a
trained independent assessor blinded to treatment status
conducts the follow-up examinations in a standardized
fashion. This minimizes potential biases introduced by
the examiner when performing the physical assessment
and recording the data. To maintain the blinded state at
each follow-up appointment, patients wear a t-shirt,
rather than a tank top, to conceal surgical scars. The asses-
sor does not have access to the patient chart. To avoid
observer bias, the physical examination and the adminis-
tration of study questionnaires are standardized across
centers. Additionally, the surgeon is blinded to the results
of the pre-operative WOSI before the patient's eligibility
has been determined. This ensures that the eligibility of
the patient is not based on subjective characteristics and
circumstances.
Data analyses
The primary analysis will involve a comparison of the
mean WOSI scores between the two surgical treatment
groups on an intention-to-treat basis. This analysis is a
two-sample independent t-test to assess whether there is a
statistically significant difference between groups for the
mean WOSI score at 2 years. The 5% significance level will
be employed. The underlying assumption for the WOSI
data is that a normal distribution will exist, but if the sam-
ple distribution is determined to depart from normal,
then a Wilcoxon rank sum test will be performed. In addi-
tion, a Generalized Estimated Equations (GEE) [70] anal-
ysis will be conducted to determine whether there is an
effect over time (repeated measures) (i.e. 3, 6, 12 months
and 2 year follow-ups).
The planned secondary analyses are performed using a 5%
significance level. No p-value adjustment is required for
multiple outcomes, as treatment effectiveness is based
only on the primary variable (i.e. WOSI score). Secondary
outcome measurements will be analyzed in the following
manner: 1) The ASES scores and Constant Scores using t-
tests and GEE analysis in a similar fashion to the primary
outcome; 2) Recurrence rates will be compared between
treatment groups using a Fisher's exact test; and, 3) Oper-
ative times between the two treatment groups will be com-
pared using a logarithmic scale and a t-test.
Data safety monitoring committee and trial steering 
committee
The Trial Steering Committee (TSC) has 4 members with
backgrounds in epidemiology, clinical trial methodology
and orthopaedic surgery. The duties of this committee are
to conduct and manage the trial, review recruitment rates
and overall compliance with data collection and study
protocol.
The Data Safety Monitoring Committee (DSMC) moni-
tors all adverse events and major complications that occur
throughout this trial. The Committee is formed by 4 inde-
pendent members who are neither investigators nor col-
laborators in this trial. Their backgrounds include
orthopaedic surgery, joint injury and arthritis research,
sport medicine and epidemiology.
The DSMC provides an advisory role to the Trial Steering
Committee and is not involved in conducting or manag-
ing the trial. The DSMC meets annually to review recruit-
ment reports and overall compliance with data collection
and study protocol, and subsequently provides feedback
and recommendations to the TSC.
In the event of a major complication, the DSMC members
hold an emergency meeting to review of the operative
report and patient chart, and determine whether the com-
plication could occur with greater incidence in one inter-
vention compared to the other. To prevent a biased
evaluation, the group is blinded to treatment allocation.
The DSMC then provides an immediate recommendation
for the TSC to decide whether the event is serious enough
to warrant stopping the trial. The TSC will weigh the ben-
Table 1: Sample size calculation for the required number of subjects in each treatment group (double sided).
Alpha level("p" value) Power
60% 70% 80% 90%
0.10 12 15 20 27
0.05 16 20 25* 33
0.01 25 30 37 47
0 . 0 0 1 4 04 65 46 5
N per group = 25* Expected dropout 12% 25/.88 = 28.4 Total per group 29 Grand Total 58 patientsTrials 2006, 7:4 http://www.trialsjournal.com/content/7/1/4
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efits of the interventions and the risks of potential adverse
events to collectively decide on the continuation or dis-
continuation of the clinical trial.
Discussion
The introduction of ETAC technology for orthopaedic use
was accepted for the treatment of shoulder instability
without the clinical evidence to support this procedure.
This randomized controlled trial will determine the effec-
tiveness of ETAC compared to the reference standard,
open ICS, in reducing capsular redundancy in a highly
selected patient population presenting with MDI or MDL-
AII, exclusive of additional shoulder pathologies. The
completion of this study has been slower than anticipated
because of unexpected practical and operational issues
addressed below.
Enrollment is slower than anticipated
The greatest difficulty encountered in this trial to date is
with enrolling eligible patients. The calculated sample size
for this trial was 58 patients, however only 49 patients
have been collectively enrolled from the participating cen-
tres between 1999 and 2005. Three reasons can explain
these difficulties. Firstly, in designing this trial, each
shoulder surgeon belonging to JOINTS Canada (Joint
Orthopaedic Initiative for National Trials of the Shoulder)
estimated that 10 to 15 patients would present with MDI
and MDL-AII in their practice annually and all patients
Flow diagram of the recruitment, allocation and follow-up process for the ETAC vs Figure 1
Flow diagram of the recruitment, allocation and follow-up process for the ETAC vs. Open ICS trial between 1999–2005.Trials 2006, 7:4 http://www.trialsjournal.com/content/7/1/4
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would be referred for surgical treatment. However, these
numbers were overestimated by each surgeon. For exam-
ple, in Calgary, a city of nearly a million people and a
catchment population of up to 2 million, only 79 patients
over a 5-year period met the clinical criteria of MDI or
MDL-AII. Therefore, the annual estimate of 10–15
patients more appropriately reflects the number of MDI
and MDL-AII patients seen in a large urban centre, rather
than per surgeon.
Secondly, the initial non-surgical rehabilitative approach
for treatment of MDI and MDL-AII patients has proved
successful in some cases. This observation combined with
patients who have withdrawn from the trial or who have
refused surgery has negatively impacted the trial enroll-
ment rate. As shown in Figure 1, at least 7 eligible patients
did not undergo surgery because of improvement with
rehabilitation, canceling or postponing surgery. Another 7
eligible patients refused research consent or withdrew
from the trial pre-operatively. Reasons for withdrawal
were based on information found over the internet or
from a physiotherapist.
Thirdly, the strict eligibility criteria have led to a high
intra-operative exclusion rate. The pre-operative clinical
diagnosis of MDI and MDL-AII, mutually exclusive of
other types of shoulder instability, is not definitive and
requires further confirmation by diagnostic arthroscopy
[71]. The presence of a Bankart lesion has been the main
reason for intra-operative exclusion. To illustrate this high
exclusion rate, of the 90 patients across Canada who have
consented to the trial and surgery, 41 (46%) have been
excluded intra-operatively, with 31 (76%) of these cases
attributed to the presence of a Bankart lesion (Figure 1).
Other reasons for intra-operative exclusion are SLAP, Hill
Sachs or ALPSA lesions, posterior labral tears and capsular
or labral holes (Figure 1). The strict criteria to exclude
additional pathologies that contribute to the shoulder
instability have consequently resulted in a slow enroll-
ment rate for the trial.
Safety considerations of open ICS and ETAC
Serious adverse events are reported to the trial's Data
Safety Monitoring Committee (DSMC), where the com-
mittee is blinded to the treatment allocation. The most
common potential complication with open ICS and ETAC
surgery is a stiff shoulder, or adhesive capsulitis. This com-
plication can be observed at similar rates with various
types of surgical shoulder procedures. In this trial to date,
two cases of adhesive capsulitis have been observed. How-
ever, the DSMC determined that the complications did
not occur with a greater incidence in one intervention
compared to the other. The Trial Steering Committee
agreed that the events were not serious enough to warrant
stopping the trial.
Transient sensory abnormalities, which are common
events with shoulder procedures and usually resolve, have
not been observed in this trial to date. There is one poten-
tial complication that is unique to the thermal procedure,
which is catastrophic capsular loss secondary to capsule
dissolution. Capsule dissolution has not been observed in
either the pilot trial or in this randomized clinical trial.
Significance of the trial
Shoulder surgeons worldwide have questioned the appli-
cation of radio-frequency thermal energy in the surgical
treatment of shoulder instability. The evaluation of the
ETAC procedure in this trial will result in a much clearer
understanding of its effectiveness and safety for the treat-
ment of patients with MDI or MDL-AII. It is anticipated
that the results of this trial will establish whether or not
this technique should be recommended for future clinical
use, or abandoned in favor of open procedures.
Conclusion
This trial was conceived at a time when Electrothermal
Arthroscopic Capsulorrhaphy was being performed in the
tens of thousands per year in North America. This tech-
nique was never tested appropriately in a clinical setting.
It was only reported anecdotally and at best, in a prospec-
tive case series. Subsequent adverse reports have resulted
in a complete turn-around in the enthusiasm of surgeons
to use this technique. The current trial has had recruit-
ment issues as a direct result of this anecdotal informa-
tion. However, there have not been any serious adverse
events to compromise the validity of completing the trial
and a number of lessons have been learned from this
study so far. These lessons include a much better under-
standing of patient recruitment, a greater appreciation of
how to define this population and the value of complet-
ing the trial in order to establish higher quality evidence.
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